Physio-biochemical and ultrastructural impact of (Fe3O4) nanoparticles on tobacco R Alkhatib, B Alkhatib, N Abdo, L Al-Eitan, R Creamer BMC plant biology 19, 1-12, 2019 | 55 | 2019 |
Metformin pharmacogenetics: effects of SLC22A1, SLC22A2, and SLC22A3 polymorphisms on glycemic control and HbA1c levels LN Al-Eitan, BA Almomani, AM Nassar, BZ Elsaqa, NA Saadeh Journal of personalized medicine 9 (1), 17, 2019 | 48 | 2019 |
Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapy LN Al-Eitan, AY Almasri, RH Khasawneh Saudi Pharmaceutical Journal 27 (4), 484-490, 2019 | 41 | 2019 |
Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy LN Al-Eitan, AY Almasri, RH Khasawneh Genes 9 (12), 578, 2018 | 37 | 2018 |
Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent LN Al-Eitan, SA Jaradat, GK Hulse, GK Tay BMC Research Notes 5, 1-11, 2012 | 36 | 2012 |
Vitamin E protects against cisplatin-induced genotoxicity in human lymphocytes LN Al-Eitan, KH Alzoubi, LI Al-Smadi, OF Khabour Toxicology In Vitro 62, 104672, 2020 | 30 | 2020 |
Evaluation of glycemic control, lifestyle and clinical characteristics in patients with type 2 diabetes treated at King Abdullah university hospital in Jordan LN Al-Eitan, AM Nassar, NA Saadeh, BA Almomani Canadian journal of diabetes 40 (6), 496-502, 2016 | 28 | 2016 |
Effects of MTHFR and ABCC2 gene polymorphisms on antiepileptic drug responsiveness in Jordanian epileptic patients LN Al-Eitan, IM Al-Dalalah, MM Mustafa, MA Alghamdi, AK Elshammari, ... Pharmacogenomics and personalized medicine, 87-95, 2019 | 25 | 2019 |
Candidate Gene Analysis of Breast Cancer In Jordanian Population Of Arab Descent: A Case-Control Study LN AL-Eitan, Reem I. Jamous, Rame H. Khasawneh Cancer Investigation, 2017 | 25 | 2017 |
The association between serum vitamin D3 levels and autism among Jordanian boys L Alzghoul, LN Al-Eitan, M Aladawi, M Odeh, O Abu Hantash Journal of autism and developmental disorders 50, 3149-3154, 2020 | 24 | 2020 |
Pharmacogenomics of genetic polymorphism within the genes responsible for SARS‐CoV‐2 susceptibility and the drug‐metabolising genes used in treatment LN AL‐Eitan, SZ Alahmad Reviews in medical virology 31 (4), e2194, 2021 | 23 | 2021 |
Association of genetic variants with level of asthma control in the Arab population BA Almomani, LN Al-Eitan, NA Al-Sawalha, SM Samrah, MN Al-Quasmi Journal of asthma and allergy, 35-42, 2019 | 21 | 2019 |
Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study LN Al-Eitan, DM Rababa’h, MA Alghamdi BMC psychiatry 21, 1-14, 2021 | 20 | 2021 |
Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility LN Al-Eitan, IM Al-Dalalah, HA Aljamal Saudi Pharmaceutical Journal 27 (5), 731-737, 2019 | 20 | 2019 |
Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent LN Al-Eitan, SA Jaradat, SYS Su, GK Tay, GK Hulse Pharmacogenomics and Personalized Medicine, 99-111, 2012 | 20 | 2012 |
Transcriptome analysis of HPV-induced warts and healthy skin in humans LN Al-Eitan, AH Tarkhan, MA Alghamdi, FA Al-Qarqaz, HS Al-Kofahi BMC Medical Genomics 13, 1-10, 2020 | 19 | 2020 |
Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population LN Al-Eitan, DM Rababa’h, MA Alghamdi, RH Khasawneh BMC medical genetics 20, 1-12, 2019 | 19 | 2019 |
Association of GSTM1, GSTT1 and GSTP1 polymorphisms with breast Cancer among Jordanian women LN Al-Eitan, DM Rababa'h, MA Alghamdi, RH Khasawneh OncoTargets and therapy, 7757-7765, 2019 | 19 | 2019 |
Role of four ABC transporter genes in pharmacogenetic susceptibility to breast cancer in Jordanian patients LN Al-Eitan, DM Rababa’h, MA Alghamdi, RH Khasawneh Journal of Oncology 2019, 2019 | 19 | 2019 |
Practical challenges and translational issues in pharmacogenomics and personalized medicine from 2010 onwards L N AL-Eitan, A H Tarkhan Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2016 | 18 | 2016 |